摘要
非酒精性脂肪性肝病(NAFLD)是一种脂质和碳水化合物新陈代谢相关的慢性疾病,并常与内质网应激、能量代谢紊乱以及细胞和分子水平的炎症有关。目前治疗非酒精性脂肪肝所使用的抗高脂血症、低血糖或抗炎药物并没有取得理想的效果。越来越多人聚焦于将天然产物作为治疗非酒精性脂肪肝的替代手段。一些天然产物通过修复脂质体和碳水化合物代谢和能量平衡而具有改善NAFLD症状的特性。本文对最近天然产物治疗NAFLD的动物和人体实验数据进行了分析,并讨论了可能的潜在机制。
关键词: 天然产物,非酒精性脂肪肝,脂肪代谢,糖代谢,炎症,内质网应激。
图形摘要
Current Drug Targets
Title:Natural Products on Nonalcoholic Fatty Liver Disease
Volume: 16 Issue: 12
Author(s): Jiao-Ya Xu, Li Zhang, Zhong-Ping Li and Guang Ji
Affiliation:
关键词: 天然产物,非酒精性脂肪肝,脂肪代谢,糖代谢,炎症,内质网应激。
摘要: Non-alcoholic fatty liver disease (NAFLD) is a chronic disorder of lipid and carbohydrate metabolism and is often associated with endoplasmic reticulum stress, energy homeostasis dysregulation, and inflammation at cellular and molecular levels. Use of currently available anti-hyperlipidemia, hypoglycemia, or anti-inflammation drugs to treat NAFLD has not achieved desirable outcomes. A growing attention thus has been paid towards natural products as an alternative means in treating NALFD. Some of the natural products apparently possess the properties of ameliorating symptoms of NAFLD through restoration of lipid and carbohydrate metabolism and energy homeostasis. Data from recent animal and human studies concerning the use of natural products in the treatment of NAFLD are analyzed, and the potential underlying mechanisms are discussed.
Export Options
About this article
Cite this article as:
Jiao-Ya Xu, Li Zhang, Zhong-Ping Li and Guang Ji , Natural Products on Nonalcoholic Fatty Liver Disease, Current Drug Targets 2015; 16 (12) . https://dx.doi.org/10.2174/1389450116666150531155711
DOI https://dx.doi.org/10.2174/1389450116666150531155711 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Subject Index To Volume 1
Recent Patents on Anti-Cancer Drug Discovery Natural and Synthetic Retinoids in Prostate Cancer
Current Pharmaceutical Design Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
Current Pharmaceutical Design Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Current Neuropharmacology Polyelectrolyte-graphene Nanocomposites for Biosensing Applications
Current Organic Chemistry Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer
Current Cancer Drug Targets The Art of Data Mining the Minefields of Toxicity Databases to Link Chemistry to Biology
Current Computer-Aided Drug Design Placental Drug Disposition and Its Clinical Implications
Current Drug Metabolism Controlled Release of Growth Factors for Regenerative Medicine
Current Pharmaceutical Design Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?
Current Drug Targets Effects of Leptin on Biliary Lipids: Potential Consequences for Gallstone Formation and Therapy in Obesity
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Expression Level and Hormonal Regulation of ABC Transporters in Breast Cancer
Current Cancer Therapy Reviews Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Current Pharmaceutical Design New Dehydroepiandrosterone-triazole Derivatives Identified as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Enzyme in the Prostate
Current Enzyme Inhibition Neuroprotective Properties of Erythropoietin in Cerebral Ischemia
Central Nervous System Agents in Medicinal Chemistry Therapeutic Targeting of Interactions Between Nef and Host Cell Proteins
Current Drug Targets - Immune, Endocrine & Metabolic Disorders